Autonomix Medical (AMIX) Capital Expenditures (2023 - 2025)

Autonomix Medical (AMIX) has reported Capital Expenditures for 3 consecutive years, with $7000.0 the latest figure, recorded in Q4 2025.

• On a quarterly basis, Capital Expenditures rose 40.0% year-over-year to $7000.0 in Q4 2025; TTM through Dec 2025 was $21000.0, a 27.59% decrease from a year earlier, with the FY2024 full-year figure at $19000.0, changed N/A from the prior year.
• Capital Expenditures was $7000.0 for Q4 2025 at Autonomix Medical, down from $14000.0 in the prior quarter.
• Over five years, Capital Expenditures peaked at $19000.0 in Q1 2024 and troughed at $5000.0 in Q2 2024.
• A 3-year average of $11000.0 and a median of $10500.0 in 2025 frame the typical range for Capital Expenditures.
• Across the five-year window, Capital Expenditures slumped 68.75% in 2024 and surged 40.0% in 2025, its largest moves.
• Over 3 years, Capital Expenditures stood at $16000.0 in 2023, then tumbled by 68.75% to $5000.0 in 2024, then surged by 40.0% to $7000.0 in 2025.
• The last three Capital Expenditures figures came in at $7000.0 (Q4 2025), $14000.0 (Q1 2025), and $5000.0 (Q4 2024), per Business Quant data.